GeneXChain announced the development of GeneXium, a healthcare platform, on the 19th. Scheduled to be released in the fourth quarter of 2024, GeneXium will redefine personalized healthcare by integrating state-of-the-art blockchain technology with user-friendly apps that allow individuals to manage their health.

GeneXChain provides personalized health solutions using AI technology based on direct-to-consumer (DTC) genetic analysis, and builds a system where individuals are rewarded with tokens through a system that allows them to choose and manage their consent to the use of their data for genetic analysis results.

The initial phase of this ambitious project is already underway, with an Android prototype currently in development. Expected to be released soon, this prototype serves as the foundation of GeneXium’s integrated ecosystem, enabling users to seamlessly access a wide range of healthcare services from providers who have partnered with GeneXChain. The focus is on delivering a cohesive, user-centric platform where multiple healthcare services can be utilized through a single, intuitive interface.

Following the launch of prototypes, JinXChain plans to launch an official version of the app early next year. This version will integrate blockchain-based DNA and personal health information, allowing users to securely manage their data on-chain within the platform. This integration fits with JinXChain’s broader roadmap, which emphasizes transparency, security, and user authorization through blockchain technology.

Ahmad Sarfaraz, CEO of GeneXChain project said, “GeneXium app marks a significant milestone in the GeneXChain project’s mission to integrate blockchain technology with healthcare. With this comprehensive platform, users will be able to not only access personalized health solutions but also have full control over their data, all within a secure and decentralized ecosystem.”

As the healthcare industry increasingly turns to digital solutions, GeneXium app is poised to set a new standard in the field, redefining the way genetic data and health services are managed. With blockchain at its core, the platform promises to deliver unparalleled levels of privacy, security, and personalization, making it a game-changer in the ongoing evolution of healthcare technology.

Contact

Amit Thapa / Marketing Manager

support2@genexchain.io

www.genexchain.io

Nay.AI to provide timely clinical interventions in saving lives

The newly introduced healthcare platform “Nay” makes use of components of Artificial Intelligence to provide timely interventions for diseases. 

Tension and stress due to medical uncertainties are ubiquitous. Health-related news of a family member or even self often makes people vulnerable. Gaping holes in the healthcare support systems turn into nightmares. Even with the best healthcare facility, no one can guarantee the right treatment.

In an attempt to bridge such vast gaps, a group of senior visionaries and industry leaders have designed Nay.AI; an ecosystem to provide just in time help to patients and intelligent decision support insights to doctors. This healthcare system aims to help UNSDG3 reach some of the goals with NLP (Natural Language Processing) and CV (Computer Vision) technology components of Artificial Intelligence. Timely and well-informed clinical interventions enabled by Nay.AI can save millions of lives in the days to come.

 

Avijit Guha, CEO at Nay, said, “Nay.AI is an equitable platform. We are bringing in a bunch of life-saving SOPs that will institute life-saving across socioeconomic classifications at par”.

The professionals in the core team of Nay have been working in the educational technology field for several decades. They have been developing software applications for dealing with education-related problems. The wide impact of COVID19 and rampant wrong treatments and ignorance around the subject influenced the team in repurposing their technology components towards saving human lives and building this history-making healthcare ecosystem, Nay. According to a clinical study at the University of Montreal, young brains lack the wisdom of elders. This gives the team of senior professionals at Nay who have extensive knowledge in their respective fields an edge over the youth-dominated start-up industry.

Mr. Guha mentioned, “We designed Nay.AI as the world’s biggest healthcare platform. Ignorance and lack of timely intervention are the biggest reasons for fatalities across the world. With Nay, we want to save as many lives as possible. We do not want people in the forthcoming world to die due to human errors or ignorance”. “It’s a long way to go; the platform is coming up brick by brick. The Neonatal and Geriatrics offerings will be available in India by the end of 2022.”

 

About Nay:

Many people lose their lives due to a lack of timely medical intervention or the non-availability of the right insights with the treating doctors. Understanding this need of the people for a healthcare venture Nay has been introduced. This healthcare venture aims to help UNSDG3 reach some of the goals with NLP (Natural Language Processing) and CV (Computer Vision) technology components of Artificial Intelligence. With the help of this, timely and well-informed clinical interventions can be provided to the patients during health emergencies.